Dr. Jamali (Doctor of Pharmacy, University of Tehran; MSc, pharmaceutics and PhD, pharmacokinetics, University of British Columbia) is a professor at the Faculty of Pharmacy and Pharm. Sci., University of Alberta. He joined the faculty at the University of Alberta in 1981.

Dr. Jamali has served as a principal investigator with the Centre of Excellence for Gastrointestinal Inflammation and Immunity Research and also with the Canadian Arthritis Network (Networks of Centres of Excellence, served as a Theme Leader). He has served as an honorary professor at the Science University of Tokyo (2010-14).

For his academic achievements and research, he has been appointed is a Fellow of the Canadian Soc. Pharm. Sci (CSPS), the American Assoc. Pharm. Sci., and the American College of Clin. Pharmacology. He has received the Killam Professorship, McKeen Cattel Memorial Award of the American College of Clin. Pharmacol., the McCalla Professorship of the University of Alberta, the McNeil Award of Assoc Canadian Faculties of Pharm., CSPS Leadership Award.

For his service to the public he has been honored with the Alberta Centennial Medal and the Alberta Pharmacy Centennial Award of Distinction.

He has been an invited or keynote speaker at many conferences.

Dr. Jamali has served as an expert witness as well as consultant and/or a member of the board of directors of many pharmaceutical houses. He has been a member of the Health Canada’s TPP Expert Advisory Committee on Bioavailabilty and Bioequivalence, and the Expert Advisory Panel on Nonsteroidal Anti-imflammatory Drugs.

He is the founding president of the Canadian Society for Pharmaceutical Sciences and founding editor of J. Pharm. & Pharm. Sci. (www.cspsCanada.org), the first open access, fully electronic peer-reviewed journal in the field.